Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Animal models to assess the toxicity, immunogenicity and effectiveness of candidate influenza vaccines.

Eichelberger MC, Green MD.

Expert Opin Drug Metab Toxicol. 2011 Sep;7(9):1117-27. doi: 10.1517/17425255.2011.602065. Epub 2011 Jul 12. Review.

PMID:
21749266
[PubMed - indexed for MEDLINE]
2.

Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.

[No authors listed]

Drugs R D. 2003;4(5):312-9. Review.

PMID:
12952502
[PubMed - indexed for MEDLINE]
3.

New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.

Steel J.

BioDrugs. 2011 Oct 1;25(5):285-98. doi: 10.2165/11593870-000000000-00000. Review.

PMID:
21942913
[PubMed - indexed for MEDLINE]
4.

Vaccines for preventing influenza in healthy children.

Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E.

Cochrane Database Syst Rev. 2012 Aug 15;8:CD004879. doi: 10.1002/14651858.CD004879.pub4. Review.

PMID:
22895945
[PubMed - indexed for MEDLINE]
5.

Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis.

Beyer WE, Nauta JJ, Palache AM, Giezeman KM, Osterhaus AD.

Vaccine. 2011 Aug 5;29(34):5785-92. doi: 10.1016/j.vaccine.2011.05.040. Epub 2011 May 30. Review.

PMID:
21624411
[PubMed - indexed for MEDLINE]
6.

Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis.

Yin JK, Khandaker G, Rashid H, Heron L, Ridda I, Booy R.

Influenza Other Respir Viruses. 2011 Sep;5(5):299-305. doi: 10.1111/j.1750-2659.2011.00229.x. Epub 2011 Mar 21. Review.

PMID:
21668694
[PubMed - indexed for MEDLINE]
7.

Human genetics and responses to influenza vaccination: clinical implications.

Lambkin R, Novelli P, Oxford J, Gelder C.

Am J Pharmacogenomics. 2004;4(5):293-8. Review.

PMID:
15462607
[PubMed - indexed for MEDLINE]
8.

Recombinant vaccines for influenza virus.

Tripp RA, Tompkins SM.

Curr Opin Investig Drugs. 2008 Aug;9(8):836-45. Review.

PMID:
18666031
[PubMed - indexed for MEDLINE]
9.

A/H5N1 prepandemic influenza vaccine (whole virion, vero cell-derived, inactivated) [Vepacel®].

Plosker GL.

Drugs. 2012 Jul 30;72(11):1543-57. doi: 10.2165/11209650-000000000-00000. Review.

PMID:
22788239
[PubMed - indexed for MEDLINE]
10.

Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine.

Durando P, Iudici R, Alicino C, Alberti M, de Florentis D, Ansaldi F, Icardi G.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:29-40. Epub 2011 Jan 1. Review.

PMID:
21245655
[PubMed - indexed for MEDLINE]
Free Article
11.
12.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinski─ş AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
[PubMed - indexed for MEDLINE]
13.

Animal models for the preclinical evaluation of candidate influenza vaccines.

Bodewes R, Rimmelzwaan GF, Osterhaus AD.

Expert Rev Vaccines. 2010 Jan;9(1):59-72. doi: 10.1586/erv.09.148. Review.

PMID:
20021306
[PubMed - indexed for MEDLINE]
14.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
[PubMed - indexed for MEDLINE]
15.

M2e-based universal influenza A vaccine.

Fiers W, De Filette M, El Bakkouri K, Schepens B, Roose K, Schotsaert M, Birkett A, Saelens X.

Vaccine. 2009 Oct 23;27(45):6280-3. doi: 10.1016/j.vaccine.2009.07.007. Review.

PMID:
19840661
[PubMed - indexed for MEDLINE]
16.

Vaccines for preventing influenza in people with asthma.

Cates CJ, Rowe BH.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD000364. doi: 10.1002/14651858.CD000364.pub4. Review.

PMID:
23450529
[PubMed - indexed for MEDLINE]
17.

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

Schotsaert M, De Filette M, Fiers W, Saelens X.

Expert Rev Vaccines. 2009 Apr;8(4):499-508. doi: 10.1586/erv.09.6. Review.

PMID:
19348565
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Pandemic H5N1 influenza vaccine development: an update.

El Sahly HM, Keitel WA.

Expert Rev Vaccines. 2008 Mar;7(2):241-7. doi: 10.1586/14760584.7.2.241. Review.

PMID:
18324892
[PubMed - indexed for MEDLINE]
19.

Inactivated influenza vaccines: recent progress and implications for the elderly.

Parodi V, de Florentiis D, Martini M, Ansaldi F.

Drugs Aging. 2011 Feb 1;28(2):93-106. doi: 10.2165/11586770-000000000-00000. Review.

PMID:
21275435
[PubMed - indexed for MEDLINE]
20.

DNA-based influenza vaccines: evaluating their potential to provide universal protection.

Choo AY, Broderick KE, Kim JJ, Sardesai NY.

IDrugs. 2010 Oct;13(10):707-12. Review.

PMID:
20878593
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk